Antiplatelet therapy in neck-remodeling device-assisted endovascular treatment for intracranial aneurysms, a multi center cohort study

Antiplatelet therapy in neck-remodeling device-assisted endovascular treatment for intracranial aneurysms, a multi center cohort study - Antiplatelet therapy in neck-remodeling device-assisted endovascular treatment for intracranial aneurysms, a multi center cohort study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043265

Enrollment

500

Registered

2025-04-01

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unruptured intracranial aneurysm

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with unruptured cerebral aneurysm over 20 years old 2) Patients who received stent-assisted neuroendovascular treatment for unruptured cerebral aneurysm from January 1, 2010 to December 31, 2020. 3) Patients who received periprocedural dual antiplatelet therapy

Exclusion criteria

Exclusion criteria: (1) Patients who could not receive sufficient preoperative antiplatelet therapy due to emergency treatment for ruptured cerebral aneurysm, symptomatic cerebral aneurysm, etc. (2) In addition, patients who are judged to be inappropriate as targets by the judgment of the investigator.

Design outcomes

Primary

Measure	Time frame
Time from endovascular treatment to onset of thromboembolic events related to target vessels, or death	—

Secondary

Measure	Time frame
1) hemorrhagic events equivalent to ISTH major bleeding 2) hemorrhagic events which required intervention by a medical professional 3) asymptomatic ischemic lesion on MRI-DWI 4) Ischemic event other than cerebrovascular disease	—

Countries

Japan

Contacts

Public Contacthirofumi Matsubara

Gifu Univeristy Graduate School of Medicine Department of Neurosurgery

hrfm.matsubara@gmail.com0582306271

Outcome results